Display options
Share it on

Front Immunol. 2021 May 25;12:693055. doi: 10.3389/fimmu.2021.693055. eCollection 2021.

Tissue-Resident Memory T Cells in Antifungal Immunity.

Frontiers in immunology

Salomé LeibundGut-Landmann

Affiliations

  1. Section of Immunology, Vetsuisse Faculty, University of Zürich, Zürich, Switzerland.
  2. Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.

PMID: 34113356 PMCID: PMC8185520 DOI: 10.3389/fimmu.2021.693055

Abstract

Fungi are an integral part of the mammalian microbiota colonizing most if not all mucosal surfaces and the skin. Maintaining stable colonization on these surfaces is critical for preventing fungal dysbiosis and infection, which in some cases can lead to life threatening consequences. The epithelial barriers are protected by T cells and additional controlling immune mechanisms. Noncirculating memory T cells that reside stably in barrier tissues play an important role for host protection from commensals and recurrent pathogens due to their fast response and local activity, which provides them a strategic advantage. So far, only a few specific examples of tissue resident memory T cells (TRMs) that act against fungi have been reported. This review provides an overview of the characteristics and functional attributes of TRMs that have been established based on human and mouse studies with various microbes. It highlights what is currently known about fungi specific TRMs mediating immunosurveillance, how they have been targeted in preclinical vaccination approaches and how they can promote immunopathology, if not controlled. A better appreciation of the host protective and damaging roles of TRMs might accelerate the development of novel tissue specific preventive strategies against fungal infections and fungi-driven immunopathologies.

Copyright © 2021 LeibundGut-Landmann.

Keywords: antifungal immunity; fungal commensals; immunopathology; pathogenic fungi; tissue-resident memory T cells (TRM); vaccine immunity (Min.5-Max. 8)

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. J Virol. 2019 Aug 28;93(18): - PubMed
  2. J Exp Med. 2020 Aug 3;217(8): - PubMed
  3. Nature. 2017 Dec 14;552(7684):253-257 - PubMed
  4. Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10416-10421 - PubMed
  5. J Immunol. 2017 Jul 1;199(1):233-243 - PubMed
  6. Cell Syst. 2016 Apr 27;2(4):225-38 - PubMed
  7. Nat Immunol. 2020 Sep;21(9):1070-1081 - PubMed
  8. J Immunol. 2011 Dec 1;187(11):5510-4 - PubMed
  9. Nature. 2012 Nov 15;491(7424):463-7 - PubMed
  10. Science. 2019 Jan 4;363(6422): - PubMed
  11. Immunity. 2013 Oct 17;39(4):687-96 - PubMed
  12. Cell Host Microbe. 2017 Dec 13;22(6):809-816.e4 - PubMed
  13. Cell. 2019 Aug 22;178(5):1176-1188.e15 - PubMed
  14. Infect Immun. 2019 Jun 20;87(7): - PubMed
  15. J Allergy Clin Immunol. 2019 Jun;143(6):2147-2157.e9 - PubMed
  16. Immunity. 2017 Feb 21;46(2):287-300 - PubMed
  17. Mucosal Immunol. 2020 Mar;13(2):334-343 - PubMed
  18. Nat Immunol. 2019 Mar;20(3):288-300 - PubMed
  19. Nat Commun. 2020 Sep 8;11(1):4475 - PubMed
  20. Nat Commun. 2015 Dec 21;6:10224 - PubMed
  21. Cell Rep. 2019 Dec 24;29(13):4236-4244.e3 - PubMed
  22. Int J Mol Med. 2018 Aug;42(2):1116-1124 - PubMed
  23. Sci Rep. 2020 Jul 7;10(1):11164 - PubMed
  24. Nat Med. 2016 Jan;22(1):72-7 - PubMed
  25. PLoS Pathog. 2016 Dec 20;12(12):e1006064 - PubMed
  26. Curr Protoc Cytom. 2013 Jan;Chapter 1:Unit1.27 - PubMed
  27. Science. 2016 Apr 22;352(6284):459-63 - PubMed
  28. Immunity. 2014 May 15;40(5):747-57 - PubMed
  29. Cell Host Microbe. 2019 Mar 13;25(3):404-417.e6 - PubMed
  30. Anal Chem. 2009 Aug 15;81(16):6813-22 - PubMed
  31. Infect Immun. 2019 Jul 23;87(8): - PubMed
  32. J Allergy Clin Immunol. 2018 Aug;142(2):647-662 - PubMed
  33. Mucosal Immunol. 2021 Mar;14(2):455-467 - PubMed
  34. Gastroenterology. 2017 Nov;153(5):1320-1337.e16 - PubMed
  35. Nature. 2015 Apr 2;520(7545):104-8 - PubMed
  36. PLoS Pathog. 2018 Sep 20;14(9):e1007260 - PubMed
  37. Science. 2012 Jun 8;336(6086):1314-7 - PubMed
  38. Lancet. 2015 Sep 5;386(9997):983-94 - PubMed
  39. Nat Immunol. 2013 Dec;14(12):1285-93 - PubMed
  40. Science. 2014 Oct 3;346(6205):98-101 - PubMed
  41. Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19739-44 - PubMed
  42. Br J Dermatol. 2019 Aug;181(2):410-412 - PubMed
  43. J Immunol. 2018 Mar 1;200(5):1561-1569 - PubMed
  44. Mucosal Immunol. 2018 Jan;11(1):249-256 - PubMed
  45. Genome Biol. 2018 Oct 22;19(1):161 - PubMed
  46. Nat Commun. 2019 Feb 12;10(1):709 - PubMed
  47. Methods Mol Biol. 2017;1508:167-182 - PubMed
  48. Science. 2014 Oct 3;346(6205):93-8 - PubMed
  49. Mucosal Immunol. 2020 May;13(3):518-529 - PubMed
  50. J Immunol. 2007 Feb 15;178(4):2387-95 - PubMed
  51. Immunol Rev. 2018 May;283(1):54-76 - PubMed
  52. Science. 2019 Oct 11;366(6462): - PubMed
  53. J Clin Invest. 2017 Nov 1;127(11):4031-4041 - PubMed
  54. Eur J Immunol. 2017 Feb;47(2):353-363 - PubMed
  55. Front Immunol. 2019 Sep 06;10:2075 - PubMed
  56. Cell Host Microbe. 2019 Mar 13;25(3):389-403.e6 - PubMed
  57. N Engl J Med. 2011 Jul 21;365(3):231-8 - PubMed
  58. J Invest Dermatol. 2013 Jan;133(1):17-26 - PubMed
  59. Proc Natl Acad Sci U S A. 2014 Apr 8;111(14):5307-12 - PubMed
  60. Cell Host Microbe. 2018 Dec 12;24(6):847-856.e4 - PubMed
  61. Nat Immunol. 2018 Oct;19(10):1126-1136 - PubMed
  62. J Immunol. 2012 Oct 1;189(7):3462-71 - PubMed
  63. Cell Host Microbe. 2016 Jun 8;19(6):865-73 - PubMed
  64. Immunity. 2015 Dec 15;43(6):1101-11 - PubMed
  65. Science. 2014 Oct 3;346(6205):101-5 - PubMed
  66. Adv Drug Deliv Rev. 2017 May 15;114:116-131 - PubMed
  67. Nat Methods. 2013 Dec;10(12):1213-8 - PubMed
  68. NPJ Vaccines. 2019 Aug 1;4:33 - PubMed
  69. J Immunol. 2012 May 15;188(10):4866-75 - PubMed
  70. Genes Immun. 2013 Jul-Aug;14(5):302-9 - PubMed
  71. Science. 2018 Jan 12;359(6372):232-236 - PubMed
  72. Mucosal Immunol. 2018 Nov;11(6):1763-1776 - PubMed
  73. Mucosal Immunol. 2015 Sep;8(5):1060-71 - PubMed
  74. Immunity. 2021 Jan 12;54(1):84-98.e5 - PubMed
  75. Lancet. 2016 Mar 12;387(10023):1109-1122 - PubMed
  76. Oncoimmunology. 2018 Mar 19;7(7):e1442163 - PubMed
  77. Vaccines (Basel). 2020 Oct 01;8(4): - PubMed
  78. Mucosal Immunol. 2019 Jan;12(1):265-276 - PubMed
  79. Nat Immunol. 2013 Dec;14(12):1294-301 - PubMed
  80. Cell. 2019 Mar 7;176(6):1340-1355.e15 - PubMed
  81. Immunity. 2016 Jan 19;44(1):155-166 - PubMed
  82. Cell Host Microbe. 2019 Mar 13;25(3):377-388.e6 - PubMed
  83. Sci Transl Med. 2018 Oct 17;10(463): - PubMed
  84. Curr Opin Microbiol. 2020 Dec;58:116-123 - PubMed
  85. Nat Immunol. 2018 Dec;19(12):1286-1298 - PubMed
  86. J Exp Med. 2015 Aug 24;212(9):1405-14 - PubMed
  87. Clin Exp Immunol. 2014 Jan;175(1):79-91 - PubMed
  88. Sci Immunol. 2019 Apr 5;4(34): - PubMed
  89. Immunity. 2019 Apr 16;50(4):892-906 - PubMed
  90. J Immunol. 2014 Apr 1;192(7):3111-20 - PubMed
  91. J Allergy Clin Immunol. 2020 Jun;145(6):1615-1628 - PubMed
  92. Immunity. 2013 Feb 21;38(2):373-83 - PubMed
  93. Nature. 2012 Feb 29;483(7388):227-31 - PubMed
  94. J Exp Med. 2017 Jun 5;214(6):1567-1580 - PubMed
  95. Nat Immunol. 2018 Feb;19(2):183-191 - PubMed
  96. Curr Opin Microbiol. 2017 Dec;40:46-57 - PubMed
  97. Nat Immunol. 2019 Nov;20(11):1469-1480 - PubMed
  98. Curr Opin Immunol. 2019 Aug;59:101-108 - PubMed
  99. J Immunol. 2017 Mar 15;198(6):2233-2237 - PubMed
  100. J Exp Med. 2014 Jun 30;211(7):1273-80 - PubMed
  101. Lancet. 2015 Jul 4;386(9988):74-84 - PubMed
  102. Proc Natl Acad Sci U S A. 2012 May 1;109(18):7037-42 - PubMed
  103. Nature. 2013 May 23;497(7450):494-7 - PubMed
  104. Nat Methods. 2009 May;6(5):377-82 - PubMed
  105. Curr Opin Immunol. 2017 Oct;48:68-73 - PubMed

Publication Types